Mitsubishi UFJ Trust & Banking
ANAB icon

Mitsubishi UFJ Trust & Banking’s AnaptysBio ANAB Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
+3,872
New +$235K ﹤0.01% 1255

Other funds holding ANAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's ANAB Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in AnaptysBio (ANAB) in Q2 2026: 3,872 shares worth $261K. The stake represents ﹤0.01% of the portfolio and ranks #1255 among its holdings.

61 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 3,872 shares of AnaptysBio worth $261K as of Q2 2026.
  • AnaptysBio was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1255 holding.
  • 61 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.